Today's Research Reports on Trending Tickers: Sarepta Therapeutics and Endo International
NEW YORK, NY / ACCESSWIRE / October 3, 2017 / U.S. markets kicked off the fourth quarter in the green Monday as investors appear optimistic that the markets record run will continue. The Dow Jones Industrial Average gained 0.68 percent to close at 22,557.60, while the S&P 500 Index gained 0.39 percent to close at 2,529.12. The NASDAQ Composite Index rose 0.32 percent to close at 6,516.72. On Monday, the Institute for Supply Management reported its manufacturing index rose to 58.8 percent in August from 56.3 percent in July, August’s reading was the highest since April 2011.
"Today is a continuation of potential enthusiasm on the tax front and the data this morning. That was a good manufacturing number," said Scott Wren, senior global equity strategist at Wells Fargo Investment Institute in St. Louis, Missouri, according to Reuters.
RDI Initiates Coverage on:
Sarepta Therapeutics Inc.
https://rdinvesting.com/news/?ticker=SRPT
Endo International plc
https://rdinvesting.com/news/?ticker=ENDP
Sarepta Therapeutics Inc.'s stock jumped 9.24% Monday, to close the day at $49.55. The stock recorded a trading volume of 4,553,016 shares, which was above its three months average volume of 2,619,850 shares. In the last year, Sarepta Therapeutics Inc.'s shares have traded in a range of 26.26 - 63.03. The share price has gained 88.69% from its 52-week low. The company's shares are currently trading above their 200-day moving average. Moreover, the stock's 50-day moving average of $40.10 is greater than its 200-day moving average of $34.92. Shares of Sarepta Therapeutics have gained approximately 80.64 percent year-to-date.
Access RDI's Sarepta Therapeutics Inc. Research Report at:
https://rdinvesting.com/news/?ticker=SRPT
On Monday, shares of Endo International plc recorded a trading volume of 6,405,722 shares, which was above the three months average volume of 5,870,230 shares. The stock ended the day 6.13% higher at 9.09. The share price has gained 22.67% from its 52-week low with a 52-week trading range of 7.41 - 21.87.The company's shares are currently trading below their 200-day moving average. Moreover, the stock's 50-day moving average of $8.73 is below its 200-day moving average of $10.80. Shares of Endo International have fallen approximately 44.81 percent year-to-date.
Access RDI's Endo International plc Research Report at:
https://rdinvesting.com/news/?ticker=ENDP
Our Actionable Research on Sarepta Therapeutics Inc. (NASDAQ: SRPT) and Endo International plc (NASDAQ: ENDP) can be downloaded free of charge at Research Driven Investing.
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
Address:
Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011
Email:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: RDInvesting.com
